ERBB2 and neoplasm: To evaluate the in vivo anti-tumor effects of HER2 CAR T cells co-expressing or singly expressing CXCR5 and CCR6, an orthotopic HCC827-Luciferase (intra-lung) tumor-bearing xenograft mouse model was established.